Singapore markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0800+0.0300 (+2.86%)
At close: 04:00PM EDT
1.0600 -0.02 (-1.85%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 132.96M
Enterprise value -7.08M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.02
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.33

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3-65.50%
S&P500 52-week change 3-4.45%
52-week high 34.3100
52-week low 30.8400
50-day moving average 31.0434
200-day moving average 31.4103

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 3790.44k
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8118.83M
% held by insiders 10.04%
% held by institutions 134.63%
Shares short (28 Jul 2022) 412.37M
Short ratio (28 Jul 2022) 415.51
Short % of float (28 Jul 2022) 49.77%
Short % of shares outstanding (28 Jul 2022) 49.77%
Shares short (prior month 29 Jun 2022) 413.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.53%
Return on equity (ttm)-15.66%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.32M
Net income avi to common (ttm)-21.49M
Diluted EPS (ttm)-0.1740
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)125.54M
Total cash per share (mrq)0.99
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)35.19
Book value per share (mrq)1.02

Cash flow statement

Operating cash flow (ttm)-17.55M
Levered free cash flow (ttm)-8.84M